| Issue Date | Title | Author(s) |
| 5-Jun-2020 | Absence of miRNA-146a Differentially Alters Microglia Function and Proteome | Martin, NA; Hyrlov, KH; Elkjaer, ML; Thygesen, EK; Wlodarczyk, A, et al |
| Jul-2020 | B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis | Reali, C; Magliozzi, R; Roncaroli, F; Nicholas, R; Howell, OW, et al |
| Mar-2021 | CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis | Magliozzi, R; Pitteri, M; Ziccardi, S; Pisani, AI; Montibeller, L, et al |
| 18-Feb-2021 | CSF proteome in multiple sclerosis subtypes related to brain lesion transcriptomes | Elkjaer, ML; Nawrocki, A; Kacprowski, T; Lassen, P; Simonsen, AH, et al |
| 21-Feb-2017 | Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study | Farina, G; Magliozzi, R; Pitteri, M; Reynolds, R; Rossi, S, et al |
| 6-May-2020 | Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain. | Donninelli, G; Saraf-Sinik, I; Mazziotti, V; Capone, A; Grasso, MG, et al |
| 23-Dec-2019 | Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing | Perez-Rodriguez, D; Kalyva, M; Leija-Salazar, M; Lashley, T; Tarabichi, M, et al |
| 1-Dec-2018 | Meningeal inflammation and cortical demyelination in acute multiple sclerosis | Bevan, RJ; Evans, R; Griffiths, L; Watkins, LM; Rees, MI, et al |
| 9-May-2019 | MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis | Uccelli, A; Laroni, A; Brundin, L; Clanet, M; Fernandez, O, et al |
| 10-Feb-2021 | Neuron-specific activation of necroptosis signaling in multiple sclerosis cortical grey matter | Picon, C; Jayaraman, A; James, R; Beck, C; Gallego, P, et al |
| 10-Jul-2017 | Patient-reported outcomes and survival in multiple sclerosis: a 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale-29 | Raffel, J; Wallace, A; Gveric, D; Reynolds, R; Friede, T, et al |
| 12-May-2020 | Persistent elevation of intrathecal pro-inflammatory cytokines leads to multiple sclerosis-like cortical demyelination and neurodegeneration. | James, RE; Schalks, R; Browne, E; Eleftheriadou, I; Munoz, CP, et al |
| 10-Nov-2021 | Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 | Swadling, L; Diniz, MO; Schmidt, NM; Amin, OE; Chandran, A, et al |
| 21-Jul-2016 | Progressive Dwindling in Multiple Sclerosis: An Opportunity to Improve Care | Martin, J; Raffel, JB; Nicholas, R; |
| 1-Aug-2018 | Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains | Mokretar, K; Pease, D; Taanman, J-W; Soenmez, A; Ejaz, A, et al |
| 21-Mar-2020 | Substantial subpial cortical demyelination in progressive multiple sclerosis: have we underestimated the extent of cortical pathology? | Griffiths, L; Reynolds, R; Evans, R; Bevan, RJ; Rees, MI, et al |
| 28-Apr-2015 | Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis | Nicholas, R; Magliozzi, R; Campbell, G; Mahad, D; Reynolds, R, et al |
| 31-Jul-2018 | Variation at the TRIM11 locus modifies Progressive Supranuclear Palsy phenotype | Jabbari, E; Woodside, J; Tan, M; Shoai, M; Pittman, A, et al |